MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

39.20 -0.82 (-2.05%)
Official Closing Price Updated: 7:00 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
News headline image
MONDAY DEADLINE: Berger Montague Advises Hims & Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Class Action by August 25, 2025
From Berger Montague
Via GlobeNewswire
News headline image
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) - August 25, 2025 Deadline to Join - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Class Action Filed Against Hims &amp; Hers Health, Inc. (HIMS) - August 25, 2025 Deadline to Join - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Healthcare Technology Stocks Q2 Highlights: Hims & Hers Health (NYSE:HIMS)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at healthcare technology stocks, starting... 
Via StockStory
News headline image
Defiance Rolls Out Leveraged ETFs Targeting AMD, Supermicro, Palantir, Hims & Robinhood ↗
Defiance ETFs introduces 5 new leveraged ETFs providing magnified exposure to popular tech, healthcare, and retail stocks, with a mix of growth and income. 
Via Benzinga
Topics ETFs
News headline image
HIMS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the August 25th Deadline for the Hims Lawsuit and Urges Investors to Contact The Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Got $5,000? 3 Tech Stocks to Buy and Hold for the Long Term ↗
As the value of your investment portfolio rises over time, you will also be better equipped for retirement. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
From Pomerantz LLP
Via GlobeNewswire
News headline image
Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Ozempic Boom: Hims & Eli Lilly Lead Healthcare Bets ↗
The race inside the weight loss industry is ramping up, leaving investors with three names to choose from in how they want to play this theme. 
Via MarketBeat
News headline image
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
From SkyMedia, LLC
Via GlobeNewswire
News headline image
Deadline Approaching for Investors of Hims & Hers Health, Inc. (HIMS) - Contact Kaplan Fox Before August 25, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Deadline Approaching for Investors of Hims &amp; Hers Health, Inc. (HIMS) - Contact Kaplan Fox Before August 25, 2025
Via TheNewswire.com
Topics Lawsuit
News headline image
HIMS Investors Have the Opportunity to Lead the Hims & Hers Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Hims & Hers Health, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Hims &amp; Hers Health, Inc. Sued for Securities Law Violations - Contact Levi &amp; Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
Why Hims & Hers Health (HIMS) Stock Is Falling Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.4% in the afternoon session after investors took some profits off the table as markets awaited signals on future monetary policy from... 
Via StockStory
Topics ETFs Economy Lawsuit
News headline image
What's Going On With Hims & Hers Shares Today? ↗
Hims & Hers Health shares are trading lower Tuesday after GoodRx announces a collaboration with Novo Nordisk. 
Via Benzinga
News headline image
Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift4 ↗
A chip stock that recently partnered with NVIDIA. Now, a key company insider is buying over $160 million in shares, a bullish signal to investors. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Autonomous Vehicles Hit an Inflection Point; GPT-5 Is Here ↗
Motley Fool Money checks in on some stock market news. 
Via The Motley Fool
Topics Economy
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Ozempic And Wegovy Now Available Through GoodRx At Reduced Self-Pay Price, Stock Skyrockets ↗
GoodRx and Novo Nordisk launch a $499 monthly self-pay option for Ozempic and Wegovy, expanding access at 70,000 pharmacies across the U.S. 
Via Benzinga
News headline image
Hims & Hers Health, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Hims &amp; Hers Health, Inc. Sued for Securities Law Violations - Investors Should Contact Levi &amp; Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. (NYSE: HIMS)
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
CoreWeave, Applied Materials And Hims & Hers Are Among Top 10 Large Cap Losers Last Week (August 11-August 15): Are The Others In Your Portfolio? ↗
Ten large-cap stocks, including CRWV, COHR & AMZN, were the worst performers last week. Weak results, downgrades, and FTC probe may be the reasons. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story